Publicacións nas que colabora con José María Prieto González (8)

2023

  1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

2021

  1. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  2. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

    Drugs, Vol. 81, Núm. 6, pp. 685-695

  3. Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter

    Neurologia, Vol. 36, Núm. 5, pp. 346-352

2018

  1. Proceso asistencial integrado de esclerosis lateral amiotrófica

    Conselleria de Sanidade

2016

  1. Clinical response and tolerability of fampridine in clinical practice

    Neurodegenerative disease management, Vol. 6, Núm. 2, pp. 99-105

  2. Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia

    Revista de Neurologia, Vol. 63, pp. S13-S18

2003

  1. Experiencia del tratamiento con interferón-β en la esclerosis múltiple en Galicia

    Revista de Neurologia, Vol. 37, Núm. 11, pp. 1001-1004